Loading provider…
Loading provider…
Cardiovascular Disease Physician in Tacoma, WA
NPI: 1144204355Primary Practice Location
TACOMA GENERAL ALLENMORE HOSPITAL
1901 S Union Ave, Tacoma, WA
Primary Employer
Multicare Health System
multicare.org
HQ Phone
Get MD Vinay's Phone Numberphone_androidMobile
Get MD Vinay's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardWA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 706 | 959 |
| 2 | 93306Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | 706 | 716 |
| 3 | 93010Routine electrocardiogram (EKG) using at least 12 leads with interpretation and report | 519 | 576 |
| 4 | 763763D radiographic procedure | 200 | 202 |
| 5 | 93015Exercise or drug-induced heart and blood vessel stress test with EKG monitoring, physician supervision, interpretation, and report | 126 | 126 |
Authors: Mark Hlatky, Rory Hachamovitch, Jeffrey Anderson, Frederick Masoudi, Daniel Mark, Michael Mcconnell, Jill Jacobs, Jeffrey Brinker, Daniel Edmundowicz, Geoffrey Rubin
Journal: J Am Coll Cardiol
Outcomes of anatomical versus functional testing for coronary artery disease.
Authors: Daniel Mark, James Udelson, Mitchell Krucoff, Lawton Cooper
Journal: N Engl J Med
Publication Date: 2015-03-14
Lead Sponsor: Celularity Incorporated
Collaborators: California Institute for Regenerative Medicine (CIRM), Access to Advanced Health Institute (AAHI), Lung Biotechnology PBC
Intervention / Treatment: BIOLOGICAL: CYNK-001
Lead Sponsor: Karyopharm Therapeutics Inc
Intervention / Treatment: OTHER: Placebo, DRUG: Selinexor
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Baricitinib